Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy

 March 20, 2024 (updated March 25, 2024) |   By Sequoia Administrator |  0 Comments

Click here to download PDF

U.S. FDA Approves Bristol Myers Squibb’s Breyanzi ® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

 March 14, 2024 (updated March 25, 2024) |   By Sequoia Administrator |  0 Comments

Click here to download PDF